Ameriprise’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Sell
36,150
-442
-1% -$2.75K ﹤0.01% 3826
2025
Q4
$209K Hold
36,592
﹤0.01% 3910
2025
Q3
$250K Sell
36,592
-258
-0.7% -$1.95K ﹤0.01% 3848
2025
Q2
$331K Buy
+36,850
New +$218K ﹤0.01% 3665

Other funds holding ULBI

Ameriprise's ULBI Position: Q1 2026 in Review

Ameriprise reduced its Ultralife (ULBI) stake by 1.2% in Q1 2026, selling an estimated $2.75K and leaving 36,150 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.

Ameriprise first reported a position in ULBI in Q2 2025 and has held it in 4 quarters since. The position peaked at $331K in Q2 2025. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Ameriprise held 36,150 shares of Ultralife worth $236K as of Q1 2026.
  • Ameriprise sold 442 Ultralife shares in Q1 2026, an estimated $2.75K.
  • Ultralife made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3826 holding.
  • Ameriprise first reported a position in Ultralife in Q2 2025 and has held it in 4 quarters since.
  • Ameriprise's Ultralife position peaked at $331K in Q2 2025.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.